Researchers at the California Institute of Technology have created a glow-in-the-dark contact lens designed to treat diabetic retinopathy.
The lenses were designed to reduce the metabolic demands of the retina, ‘by giving the rod cells the faintest amount of light to look at while the wearer sleeps’.
‘If we turn metabolism in the retina down, we should be able to prevent some of the damage that occurs,’ said Caltech graduate student Colin Cook.
The lenses are illuminated by tiny vials filled with tritium, a radioactive form of hydrogen gas that emits electrons converted into light by a phosphorescent coating, a form of technology used in watches.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here